Detail for CD133+ liver cancer stem cells

Full Name

CD133+ liver cancer stem cells

Gene Name


Related Disease

  • Liver cancer [ref.1]

Therapy Method


Liver cancer stem cells (LCSCs) can drive and maintain hepatocellular carcinoma (HCC) growth, metastasis, and recurrence. Therefore, they are potentially responsible for the poor prognosis of HCC. CD133 has emerged as an important LCSCs marker. 

Related Pathway/CSCs feature


  • [1] Autophagy contributes to the survival of CD133+ liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment.
    Cancer Lett.2013 Oct 1;339(1):70-81. [ 23879969 ]

Back to top